276
Earlypresentationofsquamouscell
carcinomaafterbonemarrowtransplantation
inaboywithFanconianemia
Apresentaçãoprecocedecarcinomadecélulasescamosasemummeninode11anos
comanemiadeFanconisubmetidoatransplantedemedulaóssea
MariaFernandaSoares1;TiagoNoguchiMachuca2;PauloRobertoBenitesFilho2;RaquelWal3;
LauroAraki4;GuilhermeCrespo5;MarcoAntônioBittencourt6;RicardoPasquini7;LuizFernandoBleggiTorres8
1.Pathologist,postgraduatestudentoftheDepartmentofPathology,HospitaldeClínicasdaUniversidadeFederaldoParaná(HC/UFPR). 2.Medicalstudent,graduateresearchfellowoftheDepartmentofPathology,HC/UFPR.
3.PathologistoftheDepartmentofPathology,HC/UFPR.
4.SurgeonoftheDepartmentofSurgicalOncology,HospitalNossaSenhoradasGraças(HNSG). 5.ResidentinSurgicalOncology,HNSG.
6.HematologistoftheBoneMarrowTransplantationUnit,HC/UFPR.
7.ChiefoftheBoneMarrowTransplantationUnitandprofessorofInternalMedicine,HC/UFPR. 8.PathologistoftheDepartmentofPathologyandprofessorofAnatomicPathology,HC/UFPR.
ThisreportwaspartiallypresentedattheXXIVBrazilianCongressofPathology,Florianópolis,fromApril30thtoMay4th,2003. TiagoNoguchiMachucaistherecipientofagrantfromtheNationalTreasure/UFPR.
abstract
Theauthorsreportacaseofan11-year-oldboywithFanconianemiapresentingwithsquamouscell carcinomaofthetongue763daysafterbonemarrowtransplantation.Fewcaseshavebeenreported intheliterature,usuallyinvolvingmucosalmembranesinadultpatients.Thefactorsrelatedtothe developmentofmalignanciesafterbonemarrowtransplantationarediscussedandtheearlypresentation ishighlighted,onceahighindexofsuspicionisrequiredfortheearlyidentificationofthiskindoflesion inchildren.
Fanconianemia
Squamouscellcarcinoma
Bonemarrowtransplantation
resumo
Osautoresrelatamocasodeummeninode11anosdeidadecomanemiadeFanconiquefoisubmetido atransplantedemedulaóssea.Com763diasdeevolução,foidetectadaumalesãoulceradanalíngua, compatívelcomcarcinomadecélulasescamosas.Poucoscasossemelhantesforamreportadosnaliteratura, geralmenteenvolvendoasmembranasmucosasempacientesadultos.Osfatoresrelacionadosaodesen-volvimentodeneoplasiassecundáriasemtransplantedemedulaósseasãodiscutidoseaidadeprecoce deapresentaçãodopacienteenfatizaanecessidadedeumaltoíndicedesuspeição,mesmoempacientes muitojovens,paraquesefaçaodiagnósticodalesãoemfaseinicial.
AnemiadeFanconi Carcinomadecélulas escamosas
Transplantedemedulaóssea
unitermos y
key words
JBrasPatolMedLab•v.40•n.4•p.276-9•agosto2004 RELATODECASO
CASEREPORT
Primeirasubmissãoem25/08/03
Últimasubmissãoem25/11/03
Aceitoparapublicaçãoem28/11/03
277
the patient developed acute GVHD followed by chronic GVHDintheoralmucosaandintheliver.Fortheinitial managementthepatientreceivedCYandcorticosteroids. Since there was no complete regression of the disease, treatmentwithazathioprinewasinstitutedandthedoses ofCYprogressivelyreduced.
Onday763,stillundertreatmentforchronicGVHDwith azathioprine,hepresentedanulceratedlesionofthetongue. Neither clinical lymphadenopathy nor signs suggesting systemic dissemination were observed. The blood count was Hb 8g/dl; white blood cells, 3,000/dl and platelets, 89,000/dl.Thefirstsuspicionwassquamouscellcarcinoma andduetoitslocalizationandextension,thelesionproved to be locally resectable. The patient underwent partial glossectomyafterafrozensectiondiagnosisofsquamouscell carcinoma.Chemotherapyandradiotherapywereavoided becauseoftheprimarydisease(FA).
Theresectedspecimenshowedaninvasivesquamouscell carcinomawithoutevidenceofvascularorperineuralspread
(Figure1).Themarginswerefreeoftumorinvolvement.
Foci of chronic GVHD, with hydropic degeneration of the basal layer and lymphocytic infiltrate, were present in the surgical specimen (Figure 2). Assessment for humanpapillomavirusinfectionwasperformedbyinsitu hybridization coupled with streptavidin-peroxidase and catalyzed signal amplification (DAKO). Probes for types 6/11,16/18,31/33andawidespectrumprobe(DAKO) wereemployed,however,nosignalwasobtained.
Discussion
FAisaninheriteddiseasecharacterizedbychromosomal instability and a series of congenital morphologic
Introduction
FanconiAnemia(FA)isarareautosomalrecessivedisease characterizedbyaseriesofcongenitalabnormalities,bone marrowfailureandincreasedpredispositiontohematologic aswellassolidtissuemalignancies(4).
WiththeimprovingmodalitiesoftreatmentofFA,the formerly reported ten-year life expectancy now reaches 30years(1).Thisprogresshasledtothedevelopmentof
lesscommonlynotedmalignanciesasthepatientsmove intoadulthood,especiallylivercancerandsquamouscell carcinomas(SCC).Besides,bonemarrowtransplantation (BMT), considered the treatment of choice for this disorder(5),correctsonlythehematologicabnormalitiesof
FAandnotitsgeneralfailuretorepairDNAdamage. FewcasesofSCCinpatientswithFApostBMThave beenreported(6,7,9).Thereappearstobeapredilectionfor
mucosaltissueintheheadandneckwithameanageof presentationof23years(1,9).Theauthorsreportacaseof
SCCofthetongueinan11-year-oldchildwithFApostBMT. Clinicopathologicandultra-structuralfeaturesaswellasa reviewofliteraturearepresented.
Case report
A 6-year-old male, blood group B and born from unrelatedparents,presentedwithlefthemiparesiain1996. Computerized tomography suggested a hemorrhagic cerebrovascularepisodeandbloodcountrevealedsevere plateletdepletion.FAwasfirstsuspectedandthepatient wasreferredtoourinstitution.Thediepoxibutanesensitivity (DEB)testprovidedtheaccuratediagnosisofFAandbone marrowtransplantationwasplanned.
ThepatientunderwentABO-incompatibleallogeneic bone marrow transplantation in February, 1997. The marrow donor was his HLA-identical AB+ blood group sisterwhodidnothaveFA.Thepre-transplantconditioning regimen consisted of cyclophosphamide (CY) 25mg/kg daily IV during four consecutive days (total dose of 100mg/kg) associated with MESNA 25mg/kg IV daily, for hemorrhagic cystitis prophylaxis. Irradiation was not included in the pre-transplant regimen. Prophylaxis for herpes virus with acyclovir, forPneumocystis carinii with trimethoprim-sulfametoxazole, and for other variants of funguswithfluconazolewereintroduced.Prophylaxisfor graft-versus-hostdisease(GVHD)consistedofcyclosporin A(CsA)andmethotrexate(MTX)accordingtotheSeattle
protocol(10). Sustained engraftment was achieved but Figure1–Tongueinvasivesquamouscellcarcinoma(hematoxylin-eosin,100x)
278
abnormalities.Ithasbeenclaimedthatitiscausedprimarily byadefectinDNAcrosslinkrepair(4).
The predisposition of FA patients to hematologic abnormalitiesandcancer,andthechronologyoftheevents hasbeenwell-documented(1).Aplasticanemiahasahigh
penetrance,developinginapproximately80%ofpatients, usuallyinthefirstdecadeoflife(1, 4).Themostcommon
hematologicmalignancyisacutemyelogenousleukemia, differingfromtheusualpediatricandadolescentpopulation pattern.Itdevelopsinapproximately9%ofpatients,ata meanageof14years.Somepatientswhodevelopleukemia havepre-existingmyelodysplasiaandtypicalcytogenetic abnormalities(1,4).
FApatientsalsopresentanincreasedincidenceofsolid tumors,particularlyliverandmucosalmembranecancer. With new approaches to hematologic abnormalities, FA patients are achieving longer survival rates and being pronetodevelopsolidorganmalignancies.Livertumors occurin9%ofpatientswithFA,atameanageof16years. Adenomas and metastatic tumors have been reported, butthemostcommonhistologicaltypeishepatocellular carcinoma(1).
Othersolidtumorsoccurlater,atameanageof23 years(1, 9). The vast majority is squamous cell carcinoma
ofmucousmembranes,includingoral,anal,esophageal
mucosaandthetongue(1,4,7-9).ItisworthnotingthatFA
patientspresentwithsolidorgantumorsatanageyounger thanthegeneralpopulation.Ourreportdescribesaboy presentingwithtongueSCCattheageof11years,much younger not only than the general population but also youngerthanaverageFA.
The treatment of FA involves transfusion support, androgens, when aplastic anemia develops, and BMT, whenfeasible.Thelatterrepresentsaneffectivecurative procedure for FA(4). However, all the process involving
BMT is also known for its increased predisposition to secondarymalignancies,especiallylymphomasandsolid organcarcinomas.Thedevelopmentofsecondarytumors afterBMTismultifactorialandinvolvesthetendencyofthe primarydisease(asinFA);exposuretoradiation,citotoxic effectsofchemotherapyandimmunosupressionrendered by the conditioning regimen; the effect of free oxygen radicals;thedisruptionofnormalregulatorymechanisms byGVHDandviralinfections,particularlywithEpstein-Barr virus,HPVandHumanHerpesvirus(2,3).
Alongwiththeincreasingnumberofreportsofsolid tumorsafterBMT,riskfactorshavebeenestablished.FA,
perse,isassociatedwithanincreasedincidenceofsolid tumorsafterBMT(2).Irradiation(eitherthoracoabdominal
ortotalbody)aspartoftheconditioningregimen,GVHD, treatmentofchronicGVHDwithazathioprineandtreatment of acute GVHD with anti-thymocyte globulin have also beenrelatedtoincreasedriskofdevelopingsolidorgan neoplasms(2, 3). Among these risk factors, our patient
developed acute and chronic GVHD, the latter having been treated with azathioprine and the former with CY andcosticosteroids.
Insummary,FApatientsreceivingBMTshouldhavea closefollow-up.Carefulexaminationshouldbedirectedto mucosalmembranes,sincethesepatientspresentincreased risk for squamous cell carcinomas. Risk factors must be consideredandavoidedwheneverfeasible.Furthermore, patientswithFAdevelopsolidorgantumorsyounger(mean 23 years old) than the population average. This report reinforcesthesedataandhighlightstheneedtoconsider anevenearlierpresentation.
Figure2–Graft-versus-hostdiseaseinthetongue,displayinghyperkeratosis, hydropicdegenerationandinfiltrationoflymphocytesinthebasallayer (hematoxylin-eosin,400x)
References
1.ALTER,B.P.Fanconi’sanemiaandmalignancies.AmJHematol,
v.53,p.99-110,1996.
2. DEEG, H. J. et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle
and Paris analysis of results in 700 patients.Blood, v. 87,
p.386-92,1996.
3. DEEG, H. J. et al. Risk factors for the development of s e c o n d a r y m a l i g n a n c i e s a f t e r b o n e m a r r ow
279
transplantation.Hematol Oncol Clin NorthAm, v. 7,
p.417-29,1993.
4.KUPFER,G.M.etal.MolecularbiologyofFanconianemia.Hematol
OncolClinNorthAm,v.11,p.1045-60,1997.
5.MEDEIROS,C.R.etal.Bonemarrowtransplantationforpatients withFanconianemia:reduceddosesofcyclophosphamide
withoutirradiationasconditioning.BoneMarrowTransplant,
v.24,p.849-52,1999.
6.MILLEN,F.J.etal.Oralsquamouscellcarcinomaafterallogeneic
bone marrow transplantation for Fanconi anaemia.Br J
Haematol,v.99,p.410-4,1997.
7.REED,K.etal.TheassociationofFanconi’sanemiaandsquamous
cellcarcinoma.Cancer,v.52,p.926-8,1983.
8. SOCIÉ, G. et al. Squamous cell carcinomas after allogeneic bonemarrowtransplantationforaplasticanemia:further
evidence of a multistep process.Transplantation, v. 66,
p.667-70,1998.
9.SOMERS,G.R.etal.Squamouscellcarcinomaofthetongue inachildwithFanconianemia:acasereportandreview
oftheliterature.PedriatrPatholLabMed,v.15,p.597-607,
1995.
10. STORB, R. et al. Marrow transplantation for severe aplastic anemia. Methotrexate and cyclosporin for prevention
ofacutegraft-versus-hostdisease.Blood,v.68,p.119-25,
1986.
Maillingaddress LuizFernandoBleggiTorres ServiçodeAnatomiaPatológica HospitaldeClínicas/UFPR RuaGeneralCarneiro,181–Centro CEP80060-900–Curitiba-PR Phone/fax:(41)264-1304 e-mail:[email protected]